NCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
Clinical Trials
7 trialsNCT06252857 2024-05-01
REDT-BCC
Maastricht University Medical Center
Recruiting
NCT05405270 2023-09-11
PRedICT-TOPIC
Catharina Ziekenhuis Eindhoven
Recruiting
NCT00189254 2022-02-07
A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ
Viatris Inc.
Completed
NCT02362152 2019-12-13
RAPID-ACT
LEO Pharma
Completed
NCT01212562 2011-09-02
IMCX
University of Ioannina
Completed
NCT00114023 2007-02-19
1-Year Follow up to the 1473-IMIQ Study
Graceway Pharmaceuticals, LLC
Completed